147 related articles for article (PubMed ID: 30711024)
1. Mutations in chemokine receptors and AIDS.
Kou J; Kuang YQ
Prog Mol Biol Transl Sci; 2019; 161():113-124. PubMed ID: 30711024
[TBL] [Abstract][Full Text] [Related]
2. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
Us D
Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
[TBL] [Abstract][Full Text] [Related]
3. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.
Saifullah M; Laghzaoui O; Ozyahyalar H; Irfan A
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2430-2463. PubMed ID: 38567606
[TBL] [Abstract][Full Text] [Related]
5. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
6. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
[TBL] [Abstract][Full Text] [Related]
7. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
[TBL] [Abstract][Full Text] [Related]
8. The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.
Becker Y
Virus Genes; 2007 Apr; 34(2):93-109. PubMed ID: 17151939
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
Seibert C; Sakmar TP
Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
[TBL] [Abstract][Full Text] [Related]
10. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.
O'Brien SJ; Moore JP
Immunol Rev; 2000 Oct; 177():99-111. PubMed ID: 11138790
[TBL] [Abstract][Full Text] [Related]
11. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
12. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
14. An intricate Web: chemokine receptors, HIV-1 and hematopoiesis.
Lee B; Doranz BJ; Ratajczak MZ; Doms RW
Stem Cells; 1998; 16(2):79-88. PubMed ID: 9554031
[TBL] [Abstract][Full Text] [Related]
15. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
16. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K; Schols D
Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
[TBL] [Abstract][Full Text] [Related]
17. [AIDS; new developments. V. The role of chemokines and chemokine receptors during infection with HIV].
Brinkman K; Koopmans PP
Ned Tijdschr Geneeskd; 1998 Mar; 142(11):566-72. PubMed ID: 9623113
[TBL] [Abstract][Full Text] [Related]
18. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).
Winkler C; Modi W; Smith MW; Nelson GW; Wu X; Carrington M; Dean M; Honjo T; Tashiro K; Yabe D; Buchbinder S; Vittinghoff E; Goedert JJ; O'Brien TR; Jacobson LP; Detels R; Donfield S; Willoughby A; Gomperts E; Vlahov D; Phair J; O'Brien SJ
Science; 1998 Jan; 279(5349):389-93. PubMed ID: 9430590
[TBL] [Abstract][Full Text] [Related]
19. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS.
Vallat AV; De Girolami U; He J; Mhashilkar A; Marasco W; Shi B; Gray F; Bell J; Keohane C; Smith TW; Gabuzda D
Am J Pathol; 1998 Jan; 152(1):167-78. PubMed ID: 9422534
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
